New U.S. body to evaluate antimicrobial products

Kastus_Master Brandmark_Col_RGB

An analytical decision-tree model framework that can be used to assess the impacts of different possible market incentives on the private and social returns to product development of new antibacterial products (in contrast to those already under development).

It is hoped that the model can be used to “nudge” pharmaceutical companies into developing a new generation of life-saving antimicrobial products.

 

Share on facebook
Facebook
Share on linkedin
LinkedIn
Share on twitter
Twitter
Share on email
Email
Share on whatsapp
WhatsApp